The FDA will hold a public meeting on the premarket application and review process Oct. 22-23. The goal of the meeting is to solicit comments on its processes and provide a dedicated venue for specific suggestions on how to further improve them. Potential topics for discussion include how to achieve greater efficiencies while applications are in review and while continuing to protect public health; how to review products that are rendered “new” due to changes made to comply with a product standard; and how to facilitate greater company consultation with the FDA prior to submitting applications.

The meetings will be held at the agency’s headquarters in Silver Spring, Md.

Photograph: Shutterstock